BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7975461)

  • 1. Direct capture of plasma factor VIII:C by ion exchange chromatography.
    Teh LC; Froger M
    Vox Sang; 1994; 67(1):8-13. PubMed ID: 7975461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of antihemophilic factor VII from human plasma by column chromatography.
    Baikar VM; Kamath MV; Vishwanathan C; Varadkar AM; Bharmal SE
    Indian J Clin Biochem; 2003 Jan; 18(1):80-6. PubMed ID: 23105376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly purified factor VIII:c concentrate prepared from cryoprecipitate by ion-exchange chromatography.
    Burnouf T; Burnouf-Radosevich M; Huart JJ; Goudemand M
    Vox Sang; 1991; 60(1):8-15. PubMed ID: 1905084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of factor VIII/von Willebrand factor from human plasma on immobilized lentil lectin.
    Zhou FL; Burnouf-Radosevich M; Burnouf T
    Protein Expr Purif; 1994 Apr; 5(2):138-43. PubMed ID: 8054845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale purification of factor VIII by affinity chromatography: optimization of process parameters.
    te Booy MP; Faber A; de Jonge E; Wolterink EP; Riethorst W; Beugeling T; Bantjes A; Over J; König BW
    J Chromatogr; 1990 Mar; 503(1):103-14. PubMed ID: 2111329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of intermediate-purity factor VIII concentrate by direct gel filtration of cryoprecipitate.
    Teh LC
    Vox Sang; 1993; 65(4):251-7. PubMed ID: 8310677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Cryoprecipitation Separation of Coagulation FVIII and Prothrombin Complex Proteins by Pseudoaffinity Calcium Elution Chromatography Using Anion Exchange Resin.
    Feliciano GP; Arimori SH; Nakao VW; Dos Santos JR; Martins EAL; Bemquerer MP; Cheng E
    Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of a bovine spongiform encephalopathy-derived agent over ion-exchange chromatography used in the preparation of concentrates of fibrinogen and factor VIII.
    Foster PR; Griffin BD; Bienek C; McIntosh RV; MacGregor IR; Somerville RA; Steele PJ; Reichl HE
    Vox Sang; 2004 Feb; 86(2):92-9. PubMed ID: 15023177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of coagulation factor VIII using chromatographic methods. Direct chromatography of plasma in anion exchange resins.
    Cheng E; Jinzenji D; Lorthiois AP; de Carvalho RR; Tanaka-Azevedo AM; Raw I; Martins EA
    Biotechnol Lett; 2010 Sep; 32(9):1207-14. PubMed ID: 20431912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of fibronectin in factor VIII/von Willebrand factor cryoprecipitation.
    Mazurier C; Samor B; Deromeuf C; Goudemand M
    Thromb Res; 1985 Mar; 37(6):651-8. PubMed ID: 3922084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatographic preparation of a therapeutic highly purified von Willebrand factor concentrate from human cryoprecipitate.
    Burnouf-Radosevich M; Burnouf T
    Vox Sang; 1992; 62(1):1-11. PubMed ID: 1580062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopurification of human factor VIII/vWF complex from plasma.
    Mejan O; Fert V; Delezay M; Delaage M; Cheballah R; Bourgois A
    Thromb Haemost; 1988 Jun; 59(3):364-71. PubMed ID: 3142074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of coagulation factor VIII by immobilized metal affinity chromatography.
    Rodrigues ES; Verinaud CI; Oliveira DS; Raw I; Lopes AP; Martins EA; Cheng E
    Biotechnol Appl Biochem; 2015; 62(3):343-8. PubMed ID: 25082654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Separation of coagulation factor VIII with high activity using gigaporous anion exchange chromatography].
    Kang L; Zhang Y; Luo J; Li Y; Zhou Y; Yu R; Su Z
    Se Pu; 2012 Jun; 30(6):618-23. PubMed ID: 23016297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in large-scale purification of factor VIII/von Willebrand factor concentrates using ion-exchange chromatography.
    Mori F; Nardini I; Rossi P; Nardini C; Farina C
    Vox Sang; 2008 Nov; 95(4):298-307. PubMed ID: 19138259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoprecipitate production: the use of additives to enhance the yield.
    Yousef H; Neurath D; Freedman M; Rock G
    Clin Lab Haematol; 2006 Aug; 28(4):237-40. PubMed ID: 16898961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor VIII:C assay: influence of buffer components used in immunoaffinity chromatography for purification of factor VIII/von Willebrand factor.
    Koops K; Hoff HS; Heethuis A; Das PC; Smit Sibinga CT
    Thromb Res; 1994 May; 74(4):347-54. PubMed ID: 8085236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombogenicity of prothrombin complex concentrates].
    Dornheim G; Klöcking HP; Wulkow R; Storch H; Töpfer G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(4):571-9. PubMed ID: 1714862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
    Hughes C; Thomas KB; Schiff P; Herrington RW; Polacsek EE; McGrath KM
    Transfusion; 1988; 28(6):566-70. PubMed ID: 3143170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper-atom identification in the active and inactive forms of plasma-derived FVIII and recombinant FVIII-delta II.
    Bihoreau N; Pin S; de Kersabiec AM; Vidot F; Fontaine-Aupart MP
    Eur J Biochem; 1994 May; 222(1):41-8. PubMed ID: 8200351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.